Clinical trial
A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to…
NCT00406965 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00406965 |
|---|---|
| Title | A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma |
| Official title | A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of HAE1 (PRO98498) in Subjects With Moderate to Severe Allergic Asthma |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Allergic Asthma |
| Intervention type | Drug |
| Interventions | HAE1 (PRO98498) |
| Enrollment | 50 |
| Start date | Dec 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Dec 4, 2006 |
| Last update posted | Jan 2, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: